{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:25:26Z","timestamp":1782825926150,"version":"3.54.5"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2998,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.jcf.2004.10.003","type":"journal-article","created":{"date-parts":[[2005,4,28]],"date-time":"2005-04-28T13:14:30Z","timestamp":1114694070000},"page":"77-87","source":"Crossref","is-referenced-by-count":59,"title":["Immunisation in the current management of cystic fibrosis patients"],"prefix":"10.1016","volume":"4","author":[{"given":"Anne","family":"Malfroot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Ciofu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alo\u00efs B.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isi","family":"Dab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2004.10.003_bib1","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.125.1_suppl.1S","article-title":"Cystic fibrisos adult care. Consensus conference report","volume":"125","author":"Yankaskas","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2004.10.003_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1067\/mpd.2002.120269","article-title":"Cystic fibrosis: a 2002 update","volume":"140","author":"Orenstein","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2004.10.003_bib3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1086\/313823","article-title":"Immunisation of pediatric solid organ transplant candidates and recipients","volume":"30","author":"Burroughs","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.82.2.141","article-title":"Immunisation against varicella in end stage and pre-end stage renal failure","volume":"88","author":"Webb","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2004.10.003_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00006454-200108000-00018","article-title":"Hepatitis A vaccine in pediatric patients affected by metabolic liver diseases","volume":"20","author":"Giacchino","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib6","first-page":"1402","article-title":"Insufficient vaccination status of children with a chronic disease","volume":"140","author":"van der Meer","year":"1996","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.jcf.2004.10.003_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.7326\/0003-4819-108-4-616","article-title":"Immunisation policies and vaccine coverage among adults. The risk for missed opportunities","volume":"108","author":"Williams","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/315648","article-title":"Morbidity of pertussis in adolescents and adults","volume":"182","author":"De Serres","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/313448","article-title":"Bordetella pertussis and chronic cough in adults","volume":"29","author":"Birkebaek","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0140-6736(93)92663-E","article-title":"Shift in age in chickenpox","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2004.10.003_bib11","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1086\/375071","article-title":"Molecular typing of Bordetella pertussis isolated recovered from Belgian children and their household members","volume":"36","author":"De Schutter","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/adc.85.4.271","article-title":"MMR vaccine-worries are not justified","volume":"85","author":"Elliman","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2004.10.003_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s004310050910","article-title":"Childhood immunisation in the European Union","volume":"157","author":"Helwig","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2004.10.003_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(03)00519-X","article-title":"Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts","volume":"3","author":"Schmitt","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00006454-199010000-00009","article-title":"Fatal varicella after a single course of corticosteroids","volume":"9","author":"Kasper","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.inf.0000129688.50588.ac","article-title":"Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection","volume":"23","author":"Lang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib17","series-title":"Viral hepatitis and liver disease","first-page":"14","article-title":"Global impact of hepatitis A virus infection: changing patterns","author":"Hadler","year":"1991"},{"key":"10.1016\/j.jcf.2004.10.003_bib18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.7326\/0003-4819-110-10-838","article-title":"Fulminant hepatitis A in intravenous drug users with a chronic liver disease","volume":"110","author":"Akriviadis","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib19","series-title":"IXth International Symposium on Viral Hepatitis, Rome","first-page":"A39","article-title":"Association between chronic liver disease and death from hepatitis A, United States, 1989\u201392 (abstract)","author":"Williams","year":"1996"},{"key":"10.1016\/j.jcf.2004.10.003_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1096-9071(199706)52:2<215::AID-JMV16>3.0.CO;2-J","article-title":"Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease","volume":"52","author":"Lee","year":"1997","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcf.2004.10.003_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.510270336","article-title":"Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease","volume":"27","author":"Keeffe","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2004.10.003_bib22","first-page":"1","article-title":"Hepatitis vaccination in patients with chronic liver disease","volume":"63","author":"Michielsen","year":"2000","journal-title":"Acta Gastro-Enterol. Belg."},{"key":"10.1016\/j.jcf.2004.10.003_bib23","first-page":"359","article-title":"Hepatitis A and hepatitis B vaccination of patients with chronic liver disease","volume":"63","author":"Bell","year":"2000","journal-title":"Acta Gastro-Enterol. Belg."},{"key":"10.1016\/j.jcf.2004.10.003_bib24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/S0264-410X(00)00457-6","article-title":"Hepatitis B: vaccination programmes in Europe\u2014an update","volume":"19","author":"Van Damme","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jcf.2004.10.003_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jmv.10091","article-title":"Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001","volume":"67","author":"Van Damme","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcf.2004.10.003_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.81.2.129","article-title":"The evolution of liver disease in cystic fibrosis","volume":"81","author":"Ling","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2004.10.003_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.103.1.52","article-title":"Clinical and genetic risk factors for cystic fibrosis-related liver disease","volume":"103","author":"Wilschanski","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2004.10.003_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005176-199707000-00005","article-title":"Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?","volume":"25","author":"Potter","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2004.10.003_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis","volume":"332","author":"Neglia","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jmv.1094","article-title":"Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults","volume":"65","author":"Van Damme","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcf.2004.10.003_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00006454-200009000-00008","article-title":"A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years","volume":"19","author":"Van Der Wielen","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-15","key":"10.1016\/j.jcf.2004.10.003_bib32","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunisation: recommendations of the Advisory Committee on Immunization Practice (ACIP)","volume":"445","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR"},{"key":"10.1016\/j.jcf.2004.10.003_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMcp031540","article-title":"Prevention of hepatitis A with the hepatitis A vaccine","volume":"350","author":"Craig","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2807\/esm.06.06.00206-en","article-title":"The EUVAC-NET survey: national measles surveillance systems in EU, Switzerland, Norway and Iceland","volume":"6","author":"Glismann","year":"2001","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jcf.2004.10.003_bib35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00006454-199907000-00010","article-title":"Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella","volume":"18","author":"Vitek","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1542\/peds.99.3.479","article-title":"Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association","volume":"99","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2004.10.003_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1542\/peds.101.1.129","article-title":"Age for routine second administration of the second dose of measles-mumps-rubella vaccine","volume":"101","author":"American Academy of Pediatrics","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2004.10.003_bib38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications","volume":"172","author":"Choo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jcf.2004.10.003_bib40","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib41","first-page":"2","volume":"vol. 11","author":"Bramley","year":"2003"},{"key":"10.1016\/j.jcf.2004.10.003_bib42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00006454-198704000-00014","article-title":"Varicella in children with cystic fibrosis","volume":"6","author":"MacDonald","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/00365549109024311","article-title":"Varicella-zoster infection in adults with cystic fibrosis: role of acyclovir","volume":"23","author":"Ong","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000196084","article-title":"Varicella pneumonia in adults. A review of pulmonary manifestations, risk factors and treatment","volume":"59","author":"Gogos","year":"1992","journal-title":"Respiration"},{"key":"10.1016\/j.jcf.2004.10.003_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1201-9712(98)90054-6","article-title":"Varicella infection and pneumonia among adults","volume":"2","author":"Pugh","year":"1998","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib46","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1378\/chest.114.2.426","article-title":"Corticosteroids in life-threatening varicella pneumonia","volume":"114","author":"Mer","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2004.10.003_bib47","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1183\/09031936.03.00103202","article-title":"Varicella pneumonia in adults","volume":"21","author":"Mohsen","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2004.10.003_bib48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0140-6736(93)92663-E","article-title":"Shift in age in chickenpox","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2004.10.003_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella-zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcf.2004.10.003_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-3046.2001.00048.x","article-title":"Varicella-zoster infection in pediatric solid-organ transplant recipients: a hospital-based study in the prevaricella vaccine era","volume":"5","author":"Pandya","year":"2001","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcf.2004.10.003_bib51","first-page":"1058","article-title":"Simultaneous administration of varicella vaccine and other recommended childhood vaccines\u2013United States, 1995\u20131999","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jcf.2004.10.003_bib52","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00431-002-1053-2","article-title":"The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium)","volume":"161","author":"Thiry","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2004.10.003_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1067\/mpd.2001.116051","article-title":"Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy","volume":"139","author":"Vessey","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2004.10.003_bib55","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMe020138","article-title":"Varicella vaccine\u2014are two doses better than one?","volume":"347","author":"Gershon","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1542\/peds.103.3.619","article-title":"Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis","volume":"103","author":"Hiatt","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2004.10.003_bib57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1651-2227.1981.tb05757.x","article-title":"Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma\u2014possible synergism with Pseudomonas aeruginosa","volume":"70","author":"Peterson","year":"1981","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.jcf.2004.10.003_bib58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-3476(05)80530-X","article-title":"Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections","volume":"117","author":"Pribble","year":"1990","journal-title":"J Paediatr"},{"key":"10.1016\/j.jcf.2004.10.003_bib59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1440-1754.1991.tb02545.x","article-title":"Impact of influenza on morbidity in children with cystic fibrosis","volume":"27","author":"Ferson","year":"1991","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jcf.2004.10.003_bib60","first-page":"662","article-title":"The effect of respiratory viral infections on patients with cystic fibrosis","volume":"143","author":"Ramsey","year":"1989","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jcf.2004.10.003_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJM200001273420402","article-title":"Influenza and the rates of hospitalization for respiratory disease among infants and young children","volume":"342","author":"Izurieta","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200001273420401","article-title":"The effect of influenza on hospitalizations, outpatient visits and courses of antibiotics in children","volume":"342","author":"Neuzil","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib63","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1056\/NEJM200006083422313","article-title":"Influenza and hospitalizations in children","volume":"342","author":"Glezen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib64","first-page":"1","article-title":"Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"51","author":"CDC","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.jcf.2004.10.003_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00063198-200205000-00010","article-title":"Influenza update: vaccine development and clinical trials","volume":"8","author":"Wareing","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib66","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.303.6802.557","article-title":"Influenza vaccination in adults with cystic fibrosis","volume":"303","author":"Ong","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2004.10.003_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/infdis\/169.2.241","article-title":"Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study","volume":"169","author":"Gruber","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/thx.47.2.112","article-title":"Acute severe deterioration in cystic fibrosis associated with influenza A virus infection","volume":"47","author":"Conway","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2004.10.003_bib69","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1128\/AAC.44.5.1163-1167.2000","article-title":"Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit vaccine in paediatric patients with cystic fibrosis","volume":"44","author":"Schaad","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2004.10.003_bib70","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1183\/09031936.01.00084301","article-title":"Influenza: vaccination and treatment","volume":"17","author":"Stephenson","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2004.10.003_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1183\/09031936.01.00084401","article-title":"Pneumococcal vaccination: current and future issues","volume":"18","author":"\u00d6rtqvist","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2004.10.003_bib72","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1542\/peds.108.4.e62","article-title":"Pre-immunization anti-pneumococcal antibody levels are protective in a majority of patients with cystic fibrosis","volume":"108","author":"Lahiri","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2004.10.003_bib73","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00007890-199001000-00027","article-title":"Increased risk of pneumococcal infections in cardiac transplant recipients","author":"Amber","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.jcf.2004.10.003_bib74","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1001\/jama.1979.03290500027016","article-title":"Risk of pneumococcal infection in renal transplant patients","volume":"241","author":"Linneman","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2004.10.003_bib75","first-page":"458","article-title":"Pneumococcal infections","volume":"vol. 452","author":"American Academy of Pediatrics","year":"2000"},{"key":"10.1016\/j.jcf.2004.10.003_bib76","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archinte.1986.00360200116019","article-title":"Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine","volume":"146","author":"Linneman","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib77","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/161.4.728","article-title":"Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type specific cell wall polysaccharide","volume":"161","author":"Musher","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/clinids\/17.1.66","article-title":"Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination","volume":"17","author":"Musher","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib79","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/515644","article-title":"Magnitude, duration, quality and function of pneumococcal vaccine responses in elderly adults","volume":"178","author":"Rubins","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib80","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib81","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2004.10.003_bib82","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1001\/archinte.1994.00420230051007","article-title":"Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials","volume":"154","author":"Fine","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib83","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00006454-199808000-00005","article-title":"Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine","volume":"17","author":"Sorensen","year":"1998","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib84","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006454-200004000-00036","article-title":"Efficacy of pneumococcal conjugate vaccines in large scale field trials","volume":"19","author":"Shinefield","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 23","key":"10.1016\/j.jcf.2004.10.003_bib85","first-page":"539s","article-title":"Indication of pneumococcal vaccination in CF patients","volume":"118","author":"Malfroot","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2004.10.003_bib86","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/00006454-200110000-00007","article-title":"Invasive pneumococcal infection in pediatric cardiac transplant patients","volume":"20","author":"Stovall","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib87","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/313984","article-title":"Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines","volume":"31","author":"Von Kries","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib88","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N Engl J Med"},{"issue":"Suppl. 30","key":"10.1016\/j.jcf.2004.10.003_bib89","first-page":"155s","article-title":"Haemophilus influenzae in the lower respiratory tract of infants and children","volume":"14","author":"De Schutter","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2004.10.003_bib90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/338259","article-title":"Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed","volume":"34","author":"Breukels","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib91","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2004.10.003_bib92","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against menigococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jcf.2004.10.003_bib93","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib94","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.11.3.430","article-title":"Respiratory syncytial virus vaccines","volume":"11","author":"Dudas","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcf.2004.10.003_bib95","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00006454-200008000-00035","article-title":"Respiratory syncytial virus vaccines: recent developments","volume":"19","author":"Piedra","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib96","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"RSV in early life and risk of wheeze and allergy by age 13","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2004.10.003_bib97","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/rmed.2000.1018","article-title":"RSV disease\u2014is there a role for prevention?","volume":"95","author":"Lenney","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib98","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1164\/ajrccm.160.3.9901004","article-title":"Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease","volume":"160","author":"Walsh","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib99","first-page":"A115","article-title":"Respiratory viral infection and pulmonary function in infants with cystic fibrosis","volume":"145","author":"Hiatt","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/adc.73.2.117","article-title":"Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis","volume":"73","author":"Smyth","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2004.10.003_bib101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/thx.47.2.109","article-title":"Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis","volume":"47","author":"Johansen","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2004.10.003_bib102","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJM198412273112602","article-title":"Association of respiratory viral infection with pulmonary deterioration in patients with cystic fibrosis","volume":"311","author":"Wang","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib103","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1099-0496(199812)26:6<371::AID-PPUL1>3.0.CO;2-N","article-title":"Severe viral respiratory infections in infants with cystic fibrosis","volume":"26","author":"Armstrong","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2004.10.003_bib104","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0022-3476(88)80008-8","article-title":"Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis","volume":"113","author":"Abman","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2004.10.003_bib105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ppul.10019","article-title":"Effects of inhaled gentamycin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study","volume":"33","author":"Heinzl","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2004.10.003_bib106","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2004.10.003_bib107","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00006454-200011000-00007","article-title":"Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season","volume":"19","author":"Sorrentino","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcf.2004.10.003_bib108","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jcf.2004.10.003_bib109","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/514138","article-title":"Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children","volume":"176","author":"Karron","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2004.10.003_bib110","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0264-410X(98)00108-X","article-title":"Maternal immunization against viral disease","volume":"16","author":"Englund","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.jcf.2004.10.003_bib111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcf.2004.10.003_bib112","first-page":"249","article-title":"Infections with Pseudomonas aeruginosa in patients with cystic fibrosis","volume":"98","author":"Tummler","year":"1997","journal-title":"Behring-Inst-Mitt"},{"key":"10.1016\/j.jcf.2004.10.003_bib113","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004630-200109000-00004","article-title":"Pseudomonas vaccination and immunotherapy: an overview","volume":"5","author":"Holder","year":"2001","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.jcf.2004.10.003_bib114","article-title":"Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis","volume":"2","author":"Keogan","year":"2000","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199305000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199305000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T14:13:30Z","timestamp":1550326410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199305000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1569199305000329"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2004.10.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}